Kiora Pharmaceuticals, Inc. (KPRX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 18.68M | 21.75M | 22.69M | 24.74M | 27.11M | 29.71M | 31.65M | 31.83M | 33.48M | 4.74M | 6.98M | 9.02M |
| Cash & Short-Term Investments | 13.87M | 17.09M | 19.38M | 20.67M | 24.11M | 26.79M | 29.04M | 27.82M | 31.28M | 2.45M | 5.4M | 7.95M |
| Cash Only | 10.96M | 8.7M | 5.51M | 1.03M | 3.77M | 3.79M | 5.64M | 6.58M | 31.28M | 2.45M | 5.4M | 7.95M |
| Short-Term Investments | 2.92M | 8.39M | 13.87M | 19.64M | 20.33M | 23M | 23.4M | 21.24M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 3.32M | 1.21M | 3.11M | 2.06M | 601.2K | 1.78M | 1.34M | 2M | 2.05M | 0 | 804.51K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | 11.51 | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 4.81M | 0 | 1.45M | 0 | 0 | 270.25K | 658.35K | 2.48M | 0 | 233.38K | 1.47M | 67.84K |
| Total Non-Current Assets | 2.54M | 2.5M | 7.17M | 7.21M | 6.91M | 6.78M | 6.86M | 8.98M | 8.96M | 8.97M | 8.91M | 10.86M |
| Property, Plant & Equipment | 388.3K | 377.5K | 419.84K | 455.86K | 157.07K | 62.4K | 135.25K | 145.81K | 107.22K | 114.95K | 57.34K | 95.1K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | 144.03x | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 2.06M | 2.06M | 6.69M | 6.69M | 6.69M | 0 | 6.69M | 8.8M | 8.81M | 8.81M | 8.82M | 10.73M |
| Long-Term Investments | 0 | 0 | 0 | 4.46K | 0 | 0 | 0 | 0 | 4.08K | 0 | 0 | 4.15K |
| Other Non-Current Assets | 92.84K | 64.25K | 62.66K | 61.01K | 68.4K | 6.72M | 34.37K | 36.3K | 39.41K | 45.03K | 36.03K | 32.37K |
| Total Assets | 21.23M | 24.25M | 29.86M | 31.95M | 34.02M | 36.48M | 38.51M | 40.81M | 42.44M | 13.71M | 15.9M | 19.88M |
| Asset Turnover | - | - | - | - | - | - | - | - | 0.57x | - | - | - |
| Asset Growth % | -37.6% | -33.52% | -22.45% | -21.73% | -19.84% | 166.08% | 142.25% | 105.25% | 156.78% | -26.59% | -10% | 28.6% |
| Total Current Liabilities | 2.8M | 3.63M | 2.58M | 3.19M | 5.27M | 6.01M | 3.53M | 1.66M | 1.59M | 1.63M | 2.1M | 1.88M |
| Accounts Payable | 594.87K | 1.06M | 241.47K | 282.54K | 942.49K | 415.59K | 660.41K | 268.64K | 323.06K | 206.26K | 125.41K | 131.32K |
| Days Payables Outstanding | 1.77K | - | - | - | - | - | - | - | - | 1.92K | - | - |
| Short-Term Debt | 178.22K | 164.46K | 0 | 0 | 0 | 0 | 0 | 0 | 47.85K | 0 | 0 | 39.01K |
| Deferred Revenue (Current) | 1.25M | 1.25M | 0 | 1.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 775.17K | 1.01M | 29.06K | -235.8K | 0 | 3.31M | 1.27M | 100K | 249.52K | 0 | 495K | 661.8K |
| Current Ratio | 6.68x | 5.99x | 8.79x | 7.76x | 5.14x | 4.94x | 8.97x | 19.22x | 21.02x | 2.90x | 3.32x | 4.79x |
| Quick Ratio | 6.68x | 5.99x | 8.79x | 7.76x | 5.14x | 4.94x | 8.97x | 19.22x | 21.02x | 2.90x | 3.32x | 4.79x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 4.49M | 4.5M | 4.87M | 6.63M | 5.04M | 4.72M | 4.95M | 6.06M | 5.94M | 5.97M | 5.69M | 4.36M |
| Long-Term Debt | 195.37K | 203.8K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 248.24K | 287.08K | 87.47K | 33.81K | 39.19K | 40.2K | 46.45K | 59.82K | 0 | 0 |
| Deferred Tax Liabilities | 102.15K | 102.15K | 0 | 490.69K | 490.69K | 0 | 0 | 0 | 779.44K | 779.44K | 0 | 689.12K |
| Other Non-Current Liabilities | 4.2M | 4.19M | 4.62M | 4.6M | 4.47M | 4.68M | 4.91M | 6.02M | 5.12M | 5.13M | 5.69M | 3.67M |
| Total Liabilities | 7.29M | 8.13M | 7.45M | 9.82M | 10.32M | 10.72M | 8.48M | 7.71M | 7.54M | 7.6M | 7.79M | 6.24M |
| Total Debt | 373.59K | 368.26K | 404.17K | 430.41K | 159.02K | 57.17K | 72.64K | 82.32K | 94.3K | 106.89K | 18.73K | 39.01K |
| Net Debt | -10.58M | -8.33M | -5.1M | -597.92K | -3.61M | -3.74M | -5.56M | -6.49M | -31.18M | -2.35M | -5.38M | -7.91M |
| Debt / Equity | 0.03x | 0.02x | 0.02x | 0.02x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.02x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | 0.01x | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | -2.36x | - | - | - |
| Interest Coverage | - | - | - | - | - | -112.18x | - | - | - | - | - | - |
| Total Equity | 13.93M | 16.13M | 22.41M | 22.13M | 23.7M | 25.76M | 30.03M | 33.1M | 34.9M | 6.11M | 8.1M | 13.64M |
| Equity Growth % | -41.21% | -37.4% | -25.37% | -33.15% | -32.1% | 321.62% | 270.56% | 142.64% | 243.7% | -46.44% | -22.98% | 55.7% |
| Book Value per Share | 3.34 | 3.93 | 5.14 | 5.55 | 5.62 | 8.58 | 7.12 | 7.94 | 1.00 | 0.79 | 1.14 | 4.15 |
| Total Shareholders' Equity | 13.93M | 16.13M | 22.41M | 22.13M | 23.7M | 25.76M | 30.03M | 33.1M | 34.9M | 6.11M | 8.1M | 13.64M |
| Common Stock | 277.61K | 275.29K | 272.01K | 272.01K | 267.68K | 267.68K | 267.68K | 267.37K | 262.58K | 77.08K | 76.92K | 69.13K |
| Retained Earnings | -156.64M | -154.22M | -147.7M | -147.73M | -145.58M | -143.38M | -139.16M | -135.75M | -133.52M | -146.98M | -144.71M | -138.95M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -228.8K | -246.14K | -243.71K | -245.77K | -297.19K | -282.16K | -75.21K | -245.73K | -264.37K | -182.8K | -266.17K | -225.86K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |